SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 22nd, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 18, 2008, between Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • January 22nd, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of January , 2008, between Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”) and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT ACCENTIA BIOPHARMACEUTICALS, INC.Security Agreement • January 22nd, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time commencing on or after the first day after the initial public announcement by the Company of the unblinded results from the SinuNase Phase 3 clinical trial, or if no such public announcement has been made on or prior to December 1, 2008, December 2, 2008 (the “Initial Exercise Date”) and ending on the close of business on the thirtieth day after the initial public announcement by the Company of the unblinded results from the SinuNase Phase 3 clinical trial, or if no such public announcement has been made on or prior to December 1, 2008, December 31, 2008 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock. The p
